![\"Eystein](\"http:\/\/k2info.w.uib.no\/files\/2013\/11\/Eystein-2-150x150.jpg\")
<\/a><\/p>\nThe research group in Endocrine Medicine is led by Professor Eystein Husebye.<\/p>\n
Endocrine Medicine, or research group G1, as has been the working title, is actually an umbrella group consisting of two groups working with closely related issues and projects, says the group\u2019s leader, professor Eystein Husebye.<\/p>\n
<\/p>\n
Professor Husebye leder en stor endokrinologisk forskningsgruppe innrettet mot forskning p\u00e5 binyresykdommer. M\u00e5let er \u00e5 belyse alle sider av disse sykdommene fra utbredelse (epidemiologi) til sykdomsmekanismer. Gruppen er derfor delt opp i ulike noder (spesialomr\u00e5der) i et forskningsnettverk. Flere kliniske studier med tanke p\u00e5 bedre behandlingsmetoder er i gang \u2013 og det forskes p\u00e5 hva som f\u00e5r kroppens immunforsvar til \u00e5 angripe binyrebarken ved Addisons sykdom. I tillegg forskes det p\u00e5 en sjelden modellsykdom \u00a0– \u00a0autoimmunt polyendokrint syndrom type 1 ( APS-I ) – for \u00e5 avdekke mekanismer bak, og sammenhenger mellom ulike sykdommer.<\/p>\n
Endokrin kirurgi er ogs\u00e5 en del av forskningsgruppen Endokrin medisin. Forskningen der ledes av professor Michael Brauckhoff \u00a0og er spesielt innrettet mot kreftsvulster i endokrine organer. De har en unik tumorbiobank bygget opp over mange \u00e5r av professor emeritus Jan Erik Varhaug. Det \u00e5 organisere gruppen under samme parably er en bevisst strategi for \u00e5 styrke milj\u00f8et, og for \u00e5 utnytte hverandres spesialkompetanse.\u00a0 Samarbeidet er allerede utvidet med mange sammenfallende prosjekter, forteller Husebye.<\/p>\n
I Israel<\/b>
\nSelv oppholder han seg for tiden i Israel. I et halv\u00e5r, fram til utp\u00e5 ny\u00e5ret forsker han p\u00e5 autoimmunitet ved The Weizmann Institute of Science (WIS).
\n-Sabbatshalv\u00e5ret ved WIS gir meg god anledning til fordypning, og til planlegging. Jeg kan konsentrere meg fullt ut om forskningen \u2013 uten ansvar for administrasjon og undervisning. Det er inspirerende \u00e5 v\u00e6re i milj\u00f8 hvor jeg som forsker eksponeres for fagfelt jeg ikke kjenner s\u00e5 godt \u2013 og \u00e5 l\u00e6re nytt! sier han.<\/p>\n
At hans forskning i Israel dreier seg om autoimmunitet kommer neppe som noen overraskelse.
\n-Her ved WIS arbeider jeg sammen med Dr. Jakub Abramson som jeg ble kjent med under et forskningsopphold ved Harvard Medical School. Abramson er ekspert p\u00e5 musemodeller med APS-1, mens vi har en av verdens storste cohorter med pasienter.\u00a0 Sammen fors\u00f8ker vi \u00e5 l\u00f8se problemer knyttet til sykdomsmekanismer. I \u00f8yeblikket har vi to spennende prosjekter g\u00e5ende som vi tror vil bli lagt merke til n\u00e5r de snart publiseres, legger han til.<\/p>\n
Liker landet<\/b>
\n-Jeg legger p\u00e5 ingen m\u00e5te skjul p\u00e5 at jeg elsker \u00e5 v\u00e6re her, fortsetter han. \u2013Israel er en fascinasjon i seg selv.\u00a0 Folket, kulturen, mangfoldet; det er spennende \u00e5 oppleve p\u00e5 n\u00e6rt holde. Likevel; jeg er p\u00e5 ingen m\u00e5te blind for det konfliktstoff landet \u2013 nasjonen \u2013 representerer. Men lyspunkt finnes. Nylig foreleste jeg for 30 barneleger ved Hadassah-sykehuset i Jerusalem. Vert var David Zangen. Hans to n\u00e6rmeste medarbeidere er begge arabiske leger; alle tre arbeider de ved arabiske sykehus i og rundt Jerusalem. S \u00e5 samkvem over grenser kan v\u00e6re fruktbart! Mens vi er inne p\u00e5 Israel: En norsk-israelsk forskningssatsing \u2013 et forskingsfond- er noe jeg b\u00e5de savner og ivrer for.\u00a0 V\u00e5r nye regjering b\u00f8r snarest f\u00e5r etablert en slik ordning i likhet med Danmark, Sverige og Finland \u2013 nasjoner vi liker \u00e5 sammenligne oss med \u00a0– \u00a0er hans lille politiske avslutningsmelding fra Israel, p\u00e5 mail en sen kveldstime.<\/p>\n
<\/p>\n
Professor Husebye is the leader of a large endocrine research group focusing on studying adrenal diseases. The goal is to shed light on all aspects of these diseases from epidemiology to disease mechanisms. The group is therefore divided into different nodes (areas of specialty) in a research network. Several clinical studies testing out better methods of treatment are under way \u2013 as well as research aimed at explaining what makes the body\u2019s immune system attack the adrenal gland as with Addison\u2019s disease. \u00a0Additionally, the group studies a rare model disease \u2013 autoimmune polyendocrine syndrome type 1 (APS-I) \u2013 in order to uncover mechanisms behind, and connections between different diseases.<\/p>\n
Endocrine surgery is also a part of the Endocrine Medicine research group. The research in this area is led by Professor Michael Brauckhoff and focuses on cancer tumors in endocrine organs. They have a unique tumor bio bank built up over many years by professor emeritus Jan Erik Varhaug. Organizing the group under the same umbrella is a conscious strategy done to strengthen endocrine research, and to exploit one another\u2019s expertise.\u00a0 This cooperation has already been extended to include many coinciding projects, according to Husebye.<\/p>\n
In Israel
\n<\/b>Husebye \u00a0himself is currently staying in Israel.\u00a0 For six months, until early 2014 he is studying autoimmunity at the Weizmann Institute of Science (WIS). <\/b><\/p>\n
– These six months of sabbatical at WIS gives me a great opportunity for specialization, and for planning. I can concentrate fully on research \u2013 without responsibility for administration or teaching. It is inspiring to be in an environment where I as a researcher am exposed to fields of study I am relatively unfamiliar with, as well as learning new things! He says.<\/p>\n
That his research in Israel concerns autoimmunity hardly comes as a surprise. \u2013 Here at WIS I work with Dr. Jakub Abramson who I got to know during a stay at Harvard Medical School. Abramson is an expert on mouse models with APS-I, while we have one of the world\u2019s largest cohorts of patients. Together we are attempting to solve problems concerning disease mechanisms. At the moment we have two exciting projects underway which we believe will be noticed when they soon are published, he adds.<\/p>\n
Enjoying the country
\n<\/b>– I am not attempting to hide that I love being here, he continues. \u2013 Israel is a fascination in itself. The people, the culture, the diversity; it is exciting to experience up close. \u00a0However; I am in no way blind to the conflicts the country \u2013 the nation \u2013 represents. But there is a light at the end of the tunnel. I recently held a lecture for 30 pediatricians at the Hadassah hospital in Jerusalem. The host was David Zangen. His two closest colleagues are both Arab doctors; all three work at Arab hospitals in and around Jerusalem. So relations across borders can be fruitful! While we are on the topic of Israel: a Norwegian-Israeli research effort \u2013 a research fund \u2013 is something I both miss and wish for. Our new government should establish something similar to what Denmark, Sweden and Finland have \u2013 nations we like to compare ourselves to \u2013 is his little political end statement from Israel, sent via mail in the late evening hours. <\/b><\/p>","protected":false},"excerpt":{"rendered":"
Forskningsgruppen i Endokrin Medisin ledes av Professor Eystein Husebye. Endokrin Medisin \u2013 eller forskningsgruppe G1,\u00a0som arbeidstittelen har v\u00e6rt, er egentlig en paraply som rommer to grupper som\u00a0 arbeider med n\u00e6rt beslektede emner og prosjekter, forteller gruppens leder professor\u00a0 Eystein Husebye.…<\/p>\n
Read more →<\/a><\/p>","protected":false},"author":2781,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[44],"tags":[],"class_list":["post-557","post","type-post","status-publish","format-standard","hentry","category-nyheter"],"_links":{"self":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/557","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/users\/2781"}],"replies":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/comments?post=557"}],"version-history":[{"count":13,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/557\/revisions"}],"predecessor-version":[{"id":632,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/557\/revisions\/632"}],"wp:attachment":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/media?parent=557"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/categories?post=557"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/tags?post=557"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![\"Eystein](\"http:\/\/k2info.w.uib.no\/en\/files\/2013\/11\/Eystein-2.jpg\/\")
<\/a><\/p>\n